X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6730) 6730
Newsletter (327) 327
Book Chapter (52) 52
Magazine Article (20) 20
Book / eBook (19) 19
Newspaper Article (14) 14
Web Resource (8) 8
Dissertation (4) 4
Publication (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4329) 4329
science & technology (4087) 4087
life sciences & biomedicine (3947) 3947
uveitis (3194) 3194
female (2883) 2883
ophthalmology (2755) 2755
male (2702) 2702
uveitis - immunology (2295) 2295
animals (2126) 2126
adult (1931) 1931
middle aged (1655) 1655
adolescent (1027) 1027
immunology (1020) 1020
aged (912) 912
autoimmune diseases - immunology (828) 828
child (787) 787
uveitis - etiology (771) 771
uveitis - drug therapy (750) 750
uveitis - pathology (717) 717
rats (702) 702
mice (628) 628
retrospective studies (623) 623
inflammation (609) 609
abridged index medicus (606) 606
disease models, animal (599) 599
uveitis - diagnosis (594) 594
eye diseases (575) 575
research (515) 515
rats, inbred lew (513) 513
uveitis, anterior - immunology (491) 491
young adult (416) 416
treatment outcome (403) 403
visual acuity (389) 389
care and treatment (383) 383
follow-up studies (377) 377
child, preschool (365) 365
uveitis - complications (361) 361
rheumatology (360) 360
autoimmune diseases - pathology (354) 354
enzyme-linked immunosorbent assay (354) 354
t-lymphocytes - immunology (346) 346
retinitis - immunology (343) 343
analysis (332) 332
eye proteins - immunology (332) 332
immunosuppressive agents - therapeutic use (330) 330
cytokines (328) 328
diagnosis (319) 319
risk factors (314) 314
autoimmunity (312) 312
patients (312) 312
research article (298) 298
arthritis (296) 296
diagnosis, differential (277) 277
aged, 80 and over (276) 276
retina (275) 275
uveitis - metabolism (273) 273
retina - immunology (267) 267
arrestin (266) 266
uveitis - genetics (264) 264
acute disease (262) 262
medicine & public health (261) 261
rabbits (261) 261
mice, inbred c57bl (259) 259
sense organs (258) 258
t cells (258) 258
uveitis - chemically induced (258) 258
autoimmune diseases (256) 256
antigens (249) 249
medical research (247) 247
recurrence (243) 243
retinol-binding proteins - immunology (240) 240
health aspects (236) 236
eye (235) 235
uveitis - epidemiology (235) 235
antigens - immunology (234) 234
fluorescein angiography (233) 233
genetic structures (227) 227
polymerase chain reaction (227) 227
uveitis - therapy (226) 226
uveitis, anterior - diagnosis (226) 226
flow cytometry (222) 222
lymphocyte activation (220) 220
medicine (218) 218
prospective studies (217) 217
uveitis, anterior - etiology (216) 216
glucocorticoids - therapeutic use (207) 207
experimental autoimmune uveitis (204) 204
time factors (203) 203
aqueous humor - immunology (199) 199
molecular sequence data (198) 198
prognosis (196) 196
uveitis - prevention & control (196) 196
uveitis - physiopathology (191) 191
autoantigens - immunology (189) 189
disease (189) 189
chronic disease (188) 188
medicine, experimental (187) 187
sarcoidosis (187) 187
uveitis, anterior - drug therapy (187) 187
retinitis - pathology (186) 186
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6535) 6535
French (163) 163
Japanese (133) 133
Russian (127) 127
German (124) 124
Chinese (64) 64
Polish (46) 46
Spanish (35) 35
Romanian (29) 29
Portuguese (24) 24
Czech (22) 22
Italian (13) 13
Dutch (5) 5
Serbian (4) 4
Croatian (3) 3
Turkish (3) 3
Hebrew (2) 2
Hungarian (2) 2
Norwegian (2) 2
Slovak (2) 2
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 07/2012, Volume 30, Issue 21, pp. 2691 - 2697
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 01/2016, Volume 113, Issue 1, pp. 158 - 163
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 04/2014, Volume 192, Issue 8, pp. 3730 - 3739
Journal Article
Journal Article
Journal Article
Journal Article
The Journal of experimental medicine, ISSN 0022-1007, 07/2008, Volume 205, Issue 7, pp. 1517 - 1522
Some immunologists have characterized T helper (Th)17 T cells as the master mediators of tissue damage in a variety of pathological conditions. New data now... 
Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Dendritic Cells - immunology | Humans | Central Nervous System - pathology | Encephalomyelitis, Autoimmune, Experimental - immunology | Interleukin-23 - genetics | Encephalomyelitis, Autoimmune, Experimental - genetics | Disease Susceptibility | Macrophages - pathology | Interleukin-17 - genetics | Interleukin-12 Subunit p35 - genetics | Interleukin-23 - immunology | Mice, Knockout | Models, Immunological | Up-Regulation - immunology | Uveitis - immunology | Mice | Uveitis - genetics | Proteins - antagonists & inhibitors | Eye - pathology | Chemokines, CXC - immunology | Interleukin-17 - immunology | Autoimmunity - genetics | Neutralization Tests | Adoptive Transfer | Paralysis - pathology | Th1 Cells - immunology | Central Nervous System - immunology | Eye - immunology | Nitric Oxide Synthase Type II - immunology | Female | Interferon-gamma - genetics | Macrophages - immunology | Neutrophils - pathology | Inflammation Mediators - immunology | Cell Line | Encephalomyelitis, Autoimmune, Experimental - pathology | Myelin Sheath - immunology | Myelin Sheath - pathology | Gene Expression Regulation - immunology | Uveitis - prevention & control | Mice, Inbred C57BL | Neutrophils - immunology | Paralysis - immunology | Up-Regulation - genetics | Proteins - immunology | Antibodies - pharmacology | Gene Expression Regulation - drug effects | Animals | Interleukin-12 Subunit p35 - immunology | Interleukin-17 - antagonists & inhibitors | Lymphocyte Activation - drug effects | Interferon-gamma - immunology | Antigens - immunology | Autoimmunity - drug effects | Uveitis - pathology | Index Medicus | Commentaries
Journal Article
Journal Article
Clinical and experimental immunology, ISSN 1365-2249, 03/2010, Volume 159, Issue 3, pp. 303 - 314
Summary Activation of complement occurs during autoimmune retinal and intraocular inflammatory disease as well as neuroretinal degenerative disorders. The... 
complement C5 | experimental autoimmune uveoretinitis | macrophage activation | autoimmunity | therapy | Autoimmunity | Complement C5 | Therapy | Macrophage activation | Experimental autoimmune uveoretinitis | Life Sciences & Biomedicine | Immunology | Science & Technology | Antigens, CD - immunology | Inflammation - pathology | Complement Membrane Attack Complex - immunology | Complement Activation - immunology | Retinitis - immunology | Signal Transduction - immunology | Inflammation - drug therapy | Complement C5 - immunology | Autoimmune Diseases - pathology | Antibodies, Monoclonal - immunology | Autoimmune Diseases - drug therapy | Complement Activation - drug effects | Disease Models, Animal | Severity of Illness Index | Nitric Oxide - immunology | Retinitis - pathology | Uveitis - drug therapy | Antibodies, Monoclonal - pharmacology | Autoimmune Diseases - immunology | Rats | Anaphylatoxins - immunology | Inflammation - immunology | Animals | Retinitis - drug therapy | Signal Transduction - drug effects | Uveitis - immunology | Interferon-gamma - immunology | Mice | Complement C5 - antagonists & inhibitors | Uveitis - pathology | Animal experimentation | Medical colleges | Analysis | Nitric oxide | Monoclonal antibodies | Ophthalmology | Biological response modifiers | Macrophages | Interferon gamma | Index Medicus | Translational Studies
Journal Article